FIRMM-pix, a brain magnetic resonance imaging (MRI) software module recently launched at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly employs visual biofeedback and gamification that coaches patients to stay still during brain MRI exams.
Is gamification the answer to reducing motion distortion during brain magnetic resonance imaging (MRI) exams?
Turing Medical Technologies has launched FIRMM-pix, a brain MRI software module, which utilizes gamification and visual biofeedback to ease patient anxiety and reduce head movement during exams.
FIRMM-pix, which was recently showcased at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly utilizes licensed movie content and a comforting guide dog in one game called Puppy Dreams to help calm patients and inform them about movements during brain MRI exams.
“Motion-induced image degradation remains a significant weakness of brain MRI, making it difficult to acquire a scan quickly. With a solution like FIRMMpix, we have the potential to conduct high-fidelity scans without compromising important data and without the need for anesthesia. Moreover, its patient-centric design fosters active participation, making the scanning process more comfortable and inclusive for patients,” noted Lawrence Tanenbaum, M.D., vice president, chief technology officer and director of advanced imaging at RadNet.
Turing Medical Technologies has launched FIRMM-pix, a brain MRI software module, which utilizes gamification and visual biofeedback to ease patient anxiety and reduce head movement during exams.
Turing Medical Technologies said FIRMM-pix is a complement to the existing FIRMM brain MRI software, which helps monitor head motion during exams and provides real-time feedback to technologists. Use of the FIRMM software can lead to a 25 percent reduction of unnecessary repeat brain MRI scans and greater than $115,000 in annual cost-savings per MRI scanner, according to the company.
(Editor’s note: For related content, see “Can Abbreviated MRI Have an Impact in Neuroimaging?” and “New MRI Study Examines Impact of Disparities with Childhood Adversity Exposure on Brain Development.”)
GE HealthCare Launches PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.